Smoltek Nanotech Holding AB (XSAT:SMOL)
0.4390
+0.0190 (4.52%)
At close: Feb 26, 2026
XSAT:SMOL Revenue
Smoltek Nanotech Holding AB had revenue of 712.00K SEK in the quarter ending September 30, 2025, with 8.87% growth. This brings the company's revenue in the last twelve months to 3.50M, down -62.78% year-over-year. In the year 2024, Smoltek Nanotech Holding AB had annual revenue of 5.13M, down -59.62%.
Revenue (ttm)
3.50M
Revenue Growth
-62.78%
P/S Ratio
22.69
Revenue / Employee
205.77K
Employees
17
Market Cap
79.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.13M | -7.58M | -59.62% |
| Dec 31, 2023 | 12.71M | 5.03M | 65.55% |
| Dec 31, 2022 | 7.68M | 1.82M | 31.11% |
| Dec 31, 2021 | 5.86M | -1.05M | -15.22% |
| Dec 31, 2020 | 6.91M | 2.44M | 54.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gullberg & Jansson AB | 270.61M |
| SolidX AB | 143.51M |
| QBNK Holding AB | 41.39M |
| Redsense Medical AB | 31.84M |
| Photocat | 22.90M |
| Vidhance AB | 22.67M |
| Touchtech AB | 22.42M |
| Genetic Analysis AS | 20.45M |